Rebecca J. Hodge

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes

Jessica Matthews, Murray Stewart, Erika H. De Boever et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 197 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long‐acting glucagon‐like peptide‐1 mimetic, in healthy subjects

Mark Bush, Jessica Matthews, Erika H. De Boever et al. · Diabetes Obesity and Metabolism · 2009 · 178 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB‐756050, in Type 2 Diabetes

Rebecca J. Hodge, Lakshmi S. Vasist Johnson, Elizabeth Gould et al. · Clinical Pharmacology in Drug Development · 2013 · 73 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

GSK2374697, a Novel Albumin-Binding Domain Antibody (AlbudAb), Extends Systemic Exposure of Exendin-4: First Study in Humans—PK/PD and Safety

R. O’Connor‐Semmes, Jian Lin, Rebecca J. Hodge et al. · Clinical Pharmacology & Therapeutics · 2014 · 49 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Effect of two dietary fibers on satiety and glycemic parameters: a randomized, double-blind, placebo-controlled, exploratory study

David M. Savastano, Rebecca J. Hodge, Derek J. Nunez et al. · Nutrition Journal · 2014 · 20 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +16